1. Home
  2. AMSC vs NVAX Comparison

AMSC vs NVAX Comparison

Compare AMSC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMSC
  • NVAX
  • Stock Information
  • Founded
  • AMSC 1987
  • NVAX 1987
  • Country
  • AMSC United States
  • NVAX United States
  • Employees
  • AMSC N/A
  • NVAX N/A
  • Industry
  • AMSC Metal Fabrications
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AMSC Consumer Discretionary
  • NVAX Health Care
  • Exchange
  • AMSC Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • AMSC 1.1B
  • NVAX 1.3B
  • IPO Year
  • AMSC 1991
  • NVAX 1995
  • Fundamental
  • Price
  • AMSC $39.32
  • NVAX $6.84
  • Analyst Decision
  • AMSC Strong Buy
  • NVAX Buy
  • Analyst Count
  • AMSC 3
  • NVAX 5
  • Target Price
  • AMSC $33.67
  • NVAX $16.60
  • AVG Volume (30 Days)
  • AMSC 1.2M
  • NVAX 4.9M
  • Earning Date
  • AMSC 08-05-2025
  • NVAX 08-07-2025
  • Dividend Yield
  • AMSC N/A
  • NVAX N/A
  • EPS Growth
  • AMSC N/A
  • NVAX N/A
  • EPS
  • AMSC 0.16
  • NVAX 2.97
  • Revenue
  • AMSC $222,818,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • AMSC $20.26
  • NVAX $56.85
  • Revenue Next Year
  • AMSC $12.73
  • NVAX N/A
  • P/E Ratio
  • AMSC $245.25
  • NVAX $2.30
  • Revenue Growth
  • AMSC 52.99
  • NVAX 25.92
  • 52 Week Low
  • AMSC $13.98
  • NVAX $5.01
  • 52 Week High
  • AMSC $41.10
  • NVAX $17.81
  • Technical
  • Relative Strength Index (RSI)
  • AMSC 71.47
  • NVAX 51.12
  • Support Level
  • AMSC $38.45
  • NVAX $6.54
  • Resistance Level
  • AMSC $40.53
  • NVAX $7.20
  • Average True Range (ATR)
  • AMSC 2.11
  • NVAX 0.28
  • MACD
  • AMSC 0.14
  • NVAX 0.06
  • Stochastic Oscillator
  • AMSC 86.91
  • NVAX 66.36

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: